keyword
MENU ▼
Read by QxMD icon Read
search

vaccinology

keyword
https://read.qxmd.com/read/30769032/a-multiepitopic-theoretical-fusion-construct-based-on-in-silico-epitope-screening-of-known-vaccine-candidates-for-protection-against-wide-range-of-enterobacterial-pathogens
#1
Ashutosh Kumar, Kusum Harjai, Sanjay Chhibber
Enterobacterial pathogens that have acquired antibiotic resistance genes are a leading cause of community and hospital acquired infections. In such a situation vaccination is considered as a better option to prevent such infections. In the current study reverse vaccinology approach has been used to select peptides from already known immunogenic proteins to design a chimeric construct. We selected Yersiniabactin receptor of Escherichia coli UMN026 and Flagellin of Stenotrophomonas maltophila. B-cell linear epitopes were predicted using Bepipred prediction tool...
February 12, 2019: Human Immunology
https://read.qxmd.com/read/30747122/elimination-of-dog-mediated-human-rabies-the-burden-of-human-rabies-in-africa
#2
K Le Roux, J Kotze, K Perrett
Hope exists for the elimination of dog-mediated human rabies in Africa. Momentum is gathering towards this goal, with an increasing number of successful demonstration projects showing that elimination is feasible. The Pan African Rabies Control Network is bringing Africa together against rabies, supported by the World Health Organization, the World Organisation for Animal Health and the Food and Agriculture Organization of the United Nations, which have a combined resolution to eliminate human deaths from dog-transmitted rabies by 2030...
August 2018: Revue Scientifique et Technique
https://read.qxmd.com/read/30745480/indian-academy-of-pediatrics-iap-advisory-committee-on-vaccines-and-immunization-practices-acvip-recommended-immunization-schedule-2018-19-and-update-on-immunization-for-children-aged-0-through-18-years
#3
S Balasubramanian, Abhay Shah, Harish K Pemde, Pallab Chatterjee, S Shivananda, Vijay Kumar Guduru, Santosh Soans, Digant Shastri, Remesh Kumar
JUSTIFICATION: There is a need to revise/review recommendations regarding existing vaccines in view of current developments in vaccinology. PROCESS: Advisory Committee on Vaccines and Immunization Practices (ACVIP) of Indian Academy of Pediatrics (IAP) reviewed the new evidence, had two meetings, and representatives of few vaccine manufacturers also presented their data. The recommendations were finalized unanimously. OBJECTIVES: To revise and review the IAP recommendations for 2018-19 and issue recommendations on existing and certain new vaccines...
December 15, 2018: Indian Pediatrics
https://read.qxmd.com/read/30717656/exploitation-of-reverse-vaccinology-and-immunoinformatics-as-promising-platform-for-genome-wide-screening-of-new-effective-vaccine-candidates-against-plasmodium-falciparum
#4
Manisha Pritam, Garima Singh, Suchit Swaroop, Akhilesh Kumar Singh, Satarudra Prakash Singh
BACKGROUND: In the current scenario, designing of world-wide effective malaria vaccine against Plasmodium falciparum remain challenging despite the significant progress has been made in last few decades. Conventional vaccinology (isolate, inactivate and inject) approaches are time consuming, laborious and expensive; therefore, the use of computational vaccinology tools are imperative, which can facilitate the design of new and promising vaccine candidates. RESULTS: In current investigation, initially 5548 proteins of P...
February 4, 2019: BMC Bioinformatics
https://read.qxmd.com/read/30659906/application-of-carbon-nanotubes-in-cancer-vaccines-achievements-challenges-and-chances
#5
REVIEW
Hatem A F M Hassan, Sandra S Diebold, Lesley A Smyth, Adam A Walters, Giovanna Lombardi, Khuloud T Al-Jamal
Tumour-specific, immuno-based therapeutic interventions can be considered as safe and effective approaches for cancer therapy. Exploitation of nano-vaccinology to intensify the cancer vaccine potency may overcome the need for administration of high vaccine doses or additional adjuvants and therefore could be a more efficient approach. Carbon nanotube (CNT) can be described as carbon sheet(s) rolled up into a cylinder that is nanometers wide and nanometers to micrometers long. Stemming from the observed capacities of CNTs to enter various types of cells via diversified mechanisms utilising energy-dependent and/or passive routes of cell uptake, the use of CNTs for the delivery of therapeutic agents has drawn increasing interests over the last decade...
January 16, 2019: Journal of Controlled Release: Official Journal of the Controlled Release Society
https://read.qxmd.com/read/30650527/exploring-the-papillomaviral-proteome-to-identify-potential-candidates-for-a-chimeric-vaccine-against-cervix-papilloma-using-immunomics-and-computational-structural-vaccinology
#6
Satyavani Kaliamurthi, Gurudeeban Selvaraj, Sathishkumar Chinnasamy, Qiankun Wang, Asma Sindhoo Nangraj, William Cs Cho, Keren Gu, Dong-Qing Wei
The human papillomavirus (HPV) 58 is considered to be the second most predominant genotype in cervical cancer incidents in China. HPV type-restriction, non-targeted delivery, and the highcost of existing vaccines necessitate continuing research on the HPV vaccine. We aimed to explore the papillomaviral proteome in order to identify potential candidates for a chimeric vaccine against cervix papilloma using computational immunology and structural vaccinology approaches. Two overlapped epitope segments (23⁻36) and (29⁻42) from the N-terminal region of the HPV58 minor capsid protein L2 are selected as capable of inducing both cellular and humoral immunity...
January 15, 2019: Viruses
https://read.qxmd.com/read/30642904/moderately-neutralizing-epitopes-in-non-functional-regions-dominate-the-antibody-response-to-plasmodium-falciparum-eba-140
#7
Nichole D Salinas, May M Paing, Jagat Adhikari, Michael L Gross, Niraj Tolia
Plasmodium falciparum Erythrocyte Binding Antigen-140 plays a role in tight junction formation during parasite invasion of red blood cells and is a potential vaccine candidate for malaria. Individuals in malaria-endemic areas possess Erythrocyte Binding Antigen-140-specific antibodies, and individuals with high antibody titers to this protein have a lower rate of re-infection by parasites. The red cell binding segment of Erythrocyte Binding Antigen-140 is comprised of two Duffy-binding-like domains called F1 and F2 that together create region II...
January 14, 2019: Infection and Immunity
https://read.qxmd.com/read/30635091/t-lymphocytes-as-measurable-targets-of-protection-and-vaccination-against-viral-disorders
#8
Anne Monette, Andrew J Mouland
Continuous epidemiological surveillance of existing and emerging viruses and their associated disorders is gaining importance in light of their abilities to cause unpredictable outbreaks as a result of increased travel and vaccination choices by steadily growing and aging populations. Close surveillance of outbreaks and herd immunity are also at the forefront, even in industrialized countries, where previously eradicated viruses are now at risk of re-emergence due to instances of strain recombination, contractions in viral vector geographies, and from their potential use as agents of bioterrorism...
2019: International Review of Cell and Molecular Biology
https://read.qxmd.com/read/30632098/from-the-bluetongue-vaccination-campaigns-in-sheep-to-overimmunization-and-ovine-asia-syndrome
#9
J Asín, M Pérez, P Pinczowski, M Gimeno, L Luján
The use of vaccines has proven to be very effective in controlling and eradicating infectious diseases, both in veterinary and human medicine; however, vaccines can be also the source of an array of problems caused by procedures such as overimmunization. Bluetongue, an orbiviral disease that affects ruminants, is best controlled by the use of inactivated vaccines. During the last years of the past decade, these vaccines were applied all over Europe to control the spreading of the disease, a goal that was accomplished; however, at the same time, several adverse effects related to the vaccination were reported...
January 10, 2019: Immunologic Research
https://read.qxmd.com/read/30594319/how-far-are-we-away-from-an-improved-vaccine-for-tuberculosis-current-efforts-and-future-prospects
#10
REVIEW
Cristina Vilaplana, Pere-Joan Cardona
Tuberculosis still is a major public health problem worldwide, and vaccines may play a major role in its eradication. However, despite 20 years of intensive research, we still do not have a better vaccine than the Bacille Calmette-Guérin vaccine, which has been used since 1921 but exhibits only limited efficacy in the field. This effort has not, however, been entirely in vain as our understanding of TB vaccinology has been substantially expanded and there are currently 17 vaccine candidates in clinical development and several more in preclinical trials...
December 26, 2018: Archivos de Bronconeumología
https://read.qxmd.com/read/30591255/would-immunization-be-the-same-without-cross-reactivity
#11
REVIEW
Ivo Vojtek, Philippe Buchy, T Mark Doherty, Bernard Hoet
"Cross-reactivity" (the observed immune response against pathogen types not specifically targeted by the vaccine antigen composition) and "cross-protection" (clinical protection against related non-vaccine microorganism types) are vaccinology concepts that are attracting renewed interest in the context of disease prevention. National health authorities are collecting mounting evidence of the importance of cross-reactivity. For some vaccines, this has been substantiated by cross-protection data from clinical studies and/or post-licensure data, where their introduction into immunization programmes has shown beneficial impacts on disease caused by related non-vaccine microorganisms...
December 24, 2018: Vaccine
https://read.qxmd.com/read/30564232/proteomics-bioinformatics-and-structure-function-antigen-mining-for-gonorrhea-vaccines
#12
REVIEW
Benjamin I Baarda, Fabian G Martinez, Aleksandra E Sikora
Expanding efforts to develop preventive gonorrhea vaccines is critical because of the serious health consequences combined with the prevalence and the dire possibility of untreatable gonorrhea. Reverse vaccinology, which includes genome and proteome mining, has proven successful in the discovery of vaccine candidates against many pathogenic bacteria. Here, we describe proteomic applications including comprehensive, quantitative proteomic platforms and immunoproteomics coupled with broad-ranging bioinformatics that have been applied for antigen mining to develop gonorrhea vaccine(s)...
2018: Frontiers in Immunology
https://read.qxmd.com/read/30560910/advancing-an-hiv-vaccine-advancing-vaccinology
#13
Dennis R Burton
No abstract text is available yet for this article.
December 18, 2018: Nature Reviews. Immunology
https://read.qxmd.com/read/30559181/technologies-to-address-antimicrobial-resistance
#14
Stephen J Baker, David J Payne, Rino Rappuoli, Ennio De Gregorio
Bacterial infections have been traditionally controlled by antibiotics and vaccines, and these approaches have greatly improved health and longevity. However, multiple stakeholders are declaring that the lack of new interventions is putting our ability to prevent and treat bacterial infections at risk. Vaccine and antibiotic approaches still have the potential to address this threat. Innovative vaccine technologies, such as reverse vaccinology, novel adjuvants, and rationally designed bacterial outer membrane vesicles, together with progress in polysaccharide conjugation and antigen design, have the potential to boost the development of vaccines targeting several classes of multidrug-resistant bacteria...
December 18, 2018: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/30555463/novel-strategies-for-malaria-vaccine-design
#15
REVIEW
Augustina Frimpong, Kwadwo Asamoah Kusi, Michael Fokuo Ofori, Wilfred Ndifon
The quest for a licensed effective vaccine against malaria remains a global priority. Even though classical vaccine design strategies have been successful for some viral and bacterial pathogens, little success has been achieved for Plasmodium falciparum , which causes the deadliest form of malaria due to its diversity and ability to evade host immune responses. Nevertheless, recent advances in vaccinology through high throughput discovery of immune correlates of protection, lymphocyte repertoire sequencing and structural design of immunogens, provide a comprehensive approach to identifying and designing a highly efficacious vaccine for malaria...
2018: Frontiers in Immunology
https://read.qxmd.com/read/30528592/motivation-for-participating-in-phase-1-vaccine-trials-comparison-of-an-influenza-and-an-ebola-randomized-controlled-trial
#16
A Cattapan, K Browne, D M Halperin, A Di Castri, P Fullsack, J Graham, J M Langley, B A Taylor, S A McNeil, S A Halperin
INTRODUCTION/HYPOTHESIS: Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014-2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study...
January 7, 2019: Vaccine
https://read.qxmd.com/read/30510147/vaccines-an-achievement-of-civilization-a-human-right-our-health-insurance-for-the-future
#17
Rino Rappuoli, Angela Santoni, Alberto Mantovani
Vaccines have made a key, cost-effective contribution to the prolongation of life expectancy and quality. Here we summarize challenges facing vaccinology and immunology at the level of society, scientific innovation, and technology in a global health perspective. We argue that vaccines represent a safety belt and life insurance for humankind.
December 3, 2018: Journal of Experimental Medicine
https://read.qxmd.com/read/30508625/identification-of-novel-immunogenic-proteins-against-streptococcus-parauberis-in-a-zebrafish-model-by-reverse-vaccinology
#18
Young Su Kim, Nam-Kyung Yoon, Nadia Karisa, Sin-Hye Seo, Jeong-Soo Lee, Sung-Sik Yoo, In-Joong Yoon, Yeu-Chun Kim, Hongweon Lee, Jungoh Ahn
Streptococcus parauberis is the major infectious agent of streptococcosis in the olive flounder (Paralichthys olivaceus), causing serious economic damage. In this study, we identified potential vaccine candidates against S. parauberis by reverse vaccinology. In total, the 2 out of 21 proteins were identified as vaccine candidates from two available S. parauberis genomes. The membrane-anchored protein SEC10/PgrA and the metal ABC transporter substrate-binding lipoprotein mtsA were potent antigenic proteins based on western blotting with mouse-derived antiserum against whole bacteria of S...
November 30, 2018: Microbial Pathogenesis
https://read.qxmd.com/read/30503655/mixed-mucosal-parenteral-immunizations-with-the-broadly-conserved-pathogenic-escherichia-coli-antigen-ssle-induce-a-robust-mucosal-and-systemic-immunity-without-affecting-the-murine-intestinal-microbiota
#19
Ilham Naili, Juliette Vinot, Barbara C Baudner, Annick Bernalier-Donadille, Mariagrazia Pizza, Mickaël Desvaux, Grégory Jubelin, Ugo D'Oro, Cecilia Buonsanti
Emergence and dissemination of multidrug resistance among pathogenic Escherichia coli have posed a serious threat to public health across developing and developed countries. In combination with a flexible repertoire of virulence mechanisms, E. coli can cause a vast range of intestinal (InPEC) and extraintestinal (ExPEC) diseases but only a very limited number of antibiotics still remains effective against this pathogen. Hence, a broad spectrum E. coli vaccine could be a promising alternative to prevent the burden of such diseases, while offering the potential for covering against several InPEC and ExPEC at once...
November 29, 2018: Vaccine
https://read.qxmd.com/read/30503096/identification-of-novel-vaccine-candidates-against-cryptosporidiosis-of-neonatal-bovines-by-reverse-vaccinology
#20
M L Tomazic, A E Rodriguez, J Lombardelli, T Poklepovich, C Garro, R Galarza, K Tiranti, M Florin-Christensen, L Schnittger
The apicomplexan protozoan Cryptosporidium parvum is an important causative agent of diarrhea of neonatal bovines. Vaccination has been proposed as an advantageous strategy against cryptosporidiosis of calves since besides protection against disease it has also the potential to prevent dissemination of infective oocysts into the environment. Antigens anchored to the parasite surface via glycosylphosphatidylinositol (GPI) are implicated in host cell attachment and invasion and represent promising vaccine candidates...
December 15, 2018: Veterinary Parasitology
keyword
keyword
171767
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"